M. Cavo

Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy : additional analyses from the AFFIRM randomized clinical trial

F. Stagno, A. Cuneo, M. Gobbi, 2014 .